Literature DB >> 8652917

Non-invasive imaging techniques in pediatric cardiology: impact on clinical decision-making.

N R Lundström1.   

Abstract

To plan the treatment of congenital heart malformations, a detailed knowledge of anatomy and hemodynamics is essential. This has previously been obtained by heart catheterization and angiocardiography. During the past 20 years, several non-invasive techniques, such as echocardiography with Doppler, magnetic resonance imaging and isotope techniques have evolved. They have profoundly changed the way we practise pediatric cardiology. For the initial investigation of a patient with suspected heart disease, echocardiography is the routine method. For the less experienced, tele-transmission to a pediatric cardiology center can be used to complement to investigation. In the preoperative investigation, echocardiography with Doppler plays an important role. In some situations, such as aortic lesions or complex cardiac malformations, magnetic resonance imaging is useful. Isotope methods have been used mainly for quantification of the degree of left-to-right shunts. During a 5-year period, 695 infants and children were operated on for a heart malformation: 40% were operated on without previous heart catheterization. For patients needing surgery before 1 month of age, 58% could be operated on based on non-invasive data alone.

Entities:  

Mesh:

Year:  1995        PMID: 8652917     DOI: 10.1111/j.1651-2227.1995.tb13838.x

Source DB:  PubMed          Journal:  Acta Paediatr Suppl        ISSN: 0803-5326


  2 in total

1.  Preoperative evaluation and surgery in isolated ventricular septal defects: a 21 year perspective.

Authors:  A Nygren; J Sunnegårdh; H Berggren
Journal:  Heart       Date:  2000-02       Impact factor: 5.994

2.  Patency of cavopulmonary connection studied by single phase electron beam computed tomography.

Authors:  Byoung Wook Choi; Young Hwan Park; Jong Kyun Lee; Dong Joon Kim; Min Jung Kim; Kyu Ok Choe
Journal:  Int J Cardiovasc Imaging       Date:  2003-10       Impact factor: 2.357

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.